Overall Survival Benefit from Trastuzumab-Based Treatment in HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis
Year: 2018
Type: article
Study design: Observational Study
Source: Oncology Research and Treatment
DOI: 10.1159/000488202
Institutions: Capital Medical University, Beijing Shijitan Hospital, Beijing Friendship Hospital, Liaoning Cancer Hospital & Institute, China-Japan Friendship Hospital, Shandong Tumor Hospital, Jiangsu Province Hospital, Jiangsu Cancer Hospital, Nanjing Medical University, University of California, Los Angeles
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2807875714